From: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis
Meta-regression model | |||||||||
---|---|---|---|---|---|---|---|---|---|
Studies characteristics | Leucopenia | Granulocytopenia | Overall response | ||||||
 | Res. | Coeff. (95% CI) | p | Res. | Coeff. (95% CI) | p | Res. | Coeff. (95% CI) | p |
Mean age | 0% | 0.94 (0.67 to 1.30) | 0.237 | 0% | 0.99 (0.97 to 1.00) | 0.080 | 64.7% | 0.99 (0.98 to 1.00) | 0.271 |
Number of R cycles | 32.9% | 0.95 (0.79 to 1.15) | 0.561 | 13.2% | 1.03 (0.97 to 1.08) | 0.255 | 66.5% | 1.01 (0.97 to 1.05) | 0.645 |